Lone Candle
Champion of Truth
“while Americans are having more and more difficulty getting access to pain-relieving opioids, the FDA forces them to wait for an alternative to opioids that people in much of the developed world have been using for years.”
https://reason.com/2024/06/20/if-opiates-are-killing-americans-why-wont-the-fda-let-us-try-an-alternative/
“Why stop with repealing the parts that could be used to target abortion? The Comstock Act’s reach is much more broad than that, and every bit could do some damage in the wrong hands.”
https://reason.com/2024/06/21/the-stop-comstock-act-doesnt-go-far-enough/
“Republican Florida Gov. Ron DeSantis’ administration is once again trying to carve out broad new exemptions to the state’s celebrated government transparency law.
This time, lawyers for DeSantis are arguing that call logs from a high-ranking staffer’s phone aren’t public record, even though the staffer was conducting government business, because it was a private phone.”
https://reason.com/2024/06/21/ron-desantis-wont-stop-trying-to-gut-floridas-public-records-law/
“Russian and Chinese companies are working together to develop an attack drone similar to Iran’s lethal Shahed, Bloomberg reported, citing unnamed European officials.
According to the officials, the companies held talks last year and began designing and testing a version of the drone earlier this year, to prepare for shipping to Russia.
The drones have yet to be deployed in Ukraine, the officials told the outlet. They didn’t specify which companies were involved.
The move would be a worrying one for Ukraine and its allies.
Russia has relied heavily on Iran’s Shahed drone and its newer and customized variants to overwhelm Ukraine’s air defenses since it launched its full-scale invasion in February 2022.
In January, Russia was suspected of using an Iranian jet-powered Shahed-238 — a significant upgrade in speed and altitude over the Shahed-136 loitering munition.
Russia has developed its own version of the Shahed drones, known as Geran-2 drones, which are similar to Shahed-136s but made with different materials, researchers at Conflict Armament Research told The New York Times last year.
However, officials told Bloomberg that one concern about the reported Russia-China partnership is that China could develop the drones at a much higher rate than Iran or Russia.
It would also be another sign of Russia’s growing reliance on China as it grapples with crippling Western economic sanctions, and would be further evidence that China has become a key enabler of Russia’s war in Ukraine, despite claims of neutrality.
The European officials did not name the drone being developed, but media outlets and Chinese defense websites have reported China is working on the Sunflower 200, an exploding attack drone that is described as similar in appearance to the Shahed 136, according to Bloomberg.”
https://www.yahoo.com/news/china-russia-collaborating-develop-attack-121502058.html
“You can add the Internal Revenue Service to the ranks of federal agencies conceding that raining taxpayer money on all and sundry to offset the negative effects of pandemic-era closures didn’t go as well as intended. Not only was a program meant to offset the cost of paying workers during lockdowns and voluntary social-distancing prone to being gamed, but the “vast majority” of claims submitted to the program show evidence of being fraudulent.”
…
“In the course of a detailed review of the Employee Retention Credit, “the IRS identified between 10% and 20% of claims fall into what the agency has determined to be the highest-risk group, which show clear signs of being erroneous claims for the pandemic-era credit,” the IRS announced June 20. “In addition to this highest risk group, the IRS analysis also estimates between 60% and 70% of the claims show an unacceptable level of risk.”
The Employee Retention Credit was offered to businesses that were shut down by government COVID-19 orders in 2020 or the first three quarters of 2021, experienced a required decline in gross receipts during that period, or qualified as a recovery startup business at the end of 2021. But it was clear early on that scammers were taking advantage of giveaways of taxpayer money, either to claim it for themselves or to pose as middlemen helping unwitting business owners file claims.
In March of 2023, the tax agency warned of “blatant attempts by promoters to con ineligible people to claim the credit.” In September of that year, it stopped processing claims amidst growing evidence that vast numbers of applications were “improper,” as the IRS delicately puts it. In March 2024, the agency announced that its Voluntary Disclosure Program had recovered $1 billion (since raised to over $2 billion) in improper payouts from participants who got to keep 20 percent of the take.
Ultimately, only “between 10% and 20% of the ERC claims show a low risk” for fraud, even by generous federal standards for throwing other people’s money at problems largely of government creation.”
…
“”The total amount of fraud across all UI [unemployment insurance] programs (including the new emergency programs) during the COVID-19 pandemic was likely between $100 billion and $135 billion—or 11% to 15% of the total UI benefits paid out during the pandemic,” the Government Accountability Office warned last September.
Earlier, the Small Business Administration’s Inspector General found more than $200 billion stolen from the Economic Injury Disaster Loan (EIDL) program and Paycheck Protection Program (PPP). “This means at least 17 percent of all COVID-19 EIDL and PPP funds were disbursed to potentially fraudulent actors,” noted the report.
With between 70 percent and 90 percent of claims for the Employee Retention Credit identified as likely scams, either the IRS is a stand-out magnet for grifters or other agencies need to return to their own investigations with a somewhat more skeptical eye.”
https://reason.com/2024/06/24/vast-majority-of-pandemic-employee-retention-credit-claims-are-likely-scams-says-irs/
“”Right now, hairstylists in Connecticut need almost a year of education before they can work at their trade,” Darwyyn Deyo, a professor of economics at San Jose State University, tells Reason. “Although efforts at improving inclusivity and equity can improve outdated state-mandated curriculum, SB 178 could also make it harder for aspiring hairstylists to afford their training by increasing the cost of education.”
Research from the Institute for Justice, published in November 2022, found that “too many licensing burdens are excessively onerous or entirely unnecessary” because “red tape forces aspiring workers to waste time and money or, worse yet, shuts them out of work.”
One of the authors of that study, Kyle Sweetland, a research analyst at the Pacific Legal Foundation, tells Reason that the new Connecticut law is no exception. “While everyone loves to get a good haircut,” Sweetland says, “requiring beauticians in Connecticut to spend more hours in training—as Public Act No. 24-53 will do—is unfair to debt-burdened beauticians in the state and could lead to higher prices for customers.”
“If there is an unmet demand and high prices for cutting a certain type of hair,” he adds, “salons have a strong financial incentive to train their beauticians on cutting this type of hair—or to hire beauticians who know how to do so already.””
https://reason.com/2024/06/27/connecticut-implements-mandatory-inclusivity-training-for-cosmetologists/
“Was OxyContin in fact “central” to the upward trend in opioid-related deaths? Estimates from the National Household Survey on Drug Abuse (now the National Survey on Drug Use and Health) indicate that nonmedical use of prescription pain relievers rose for 11 consecutive years before OxyContin was introduced, and then continued to rise. Even during the period highlighted by Gorsuch, OxyContin never accounted for a very large share of the prescription analgesic market.
Defending itself against all of those lawsuits, Purdue presented Drug Enforcement Administration data indicating that OxyContin accounted for just 3.3 percent of pain pills sold in the United States from 2006 through 2012. After adjusting for potency, ProPublica calculated that the product’s “real” share of the market was more like 16 percent.
ProPublica’s analysis is questionable, assuming the concern is how many opportunities nonmedical users have to get their hands on prescription opioids. But either way, the vast majority of pain reliever prescriptions involved products other than OxyContin, most commonly hydrocodone pills such as Vicodin and oxycodone pills such as Percocet. Those latter two types of products also figured prominently in the pain relievers consumed by nonmedical users, accounting for 75 percent of the total in 2018, according to the federal government’s survey data. OxyContin, by comparison, accounted for 11 percent of nonmedical use that year.”
…
“According to a 2007 American Journal of Psychiatry study of OxyContin users admitted to drug treatment programs, 78 percent “reported that the drug had not been prescribed to them for any medical reason.”
Since Gorsuch and Kavanaugh both fault Purdue for contributing to opioid-related deaths by misrepresenting OxyContin as abuse-resistant, it is instructive to consider what happened after the company tried to make good on that promise by reformulating the drug. The new version, introduced in 2010, was much harder to crush for snorting or injection. The idea was to deter nonmedical use, and the hope was that the reformulation would reduce addiction and opioid-related deaths. That is not how things worked out.
The reformulation of OxyContin was instead associated with an increase in deaths involving illicit opioids and, ultimately, an overall increase in fatal drug overdoses. Researchers identified that pattern by looking at the relationship between pre-2010 rates of OxyContin misuse, as measured by surveys, and subsequent overdose trends. They found that death rates rose fastest in states where reformulation would have had the biggest impact.
The root cause of that perverse effect was the substitution that occurred after the old version of OxyContin was retired. Nonmedical users turned to black-market alternatives that were more dangerous because their potency was highly variable and unpredictable—a hazard that was compounded by the emergence of illicit fentanyl as a heroin booster and substitute. Nowadays illicit fentanyl accounts for around 90 percent of opioid-related deaths, which have reached record levels in recent years.
Interventions like the reformulation of OxyContin and the broader crackdown on opioid prescriptions not only failed to turn the tide. They contributed to the upward trend that Gorsuch blames on OxyContin. The story that he and Kavanaugh credulously echo turned out to be deadly as well as misleading.”
https://reason.com/2024/06/27/divided-over-purdue-pharma-deal-scotus-unites-in-accepting-a-dubious-oxycontin-narrative/
What the North Korea-Russia Alliance Reveals
https://www.youtube.com/watch?v=8EzuxeIQP14
“Former President Donald Trump helped negotiate the U.S. withdrawal from Afghanistan, ending America’s longest foreign war. But now he believes that the United States should have kept its largest base in Afghanistan to help in a future conflict against China.
During this week’s Republican National Convention, speaker after speaker has tried to transform “America First” from a slogan against overseas entanglements into a cry for more aggressive military force. And the gambit seems to have succeeded. A day after Trump’s running mate, Sen. J.D. Vance (R–Ohio), condemned the war in Afghanistan as a failure, Trump himself called for using Afghanistan as a springboard to future conflicts.”
https://reason.com/2024/07/19/trump-wishes-americans-stayed-in-afghanistan-to-fight-china/
Palestinian Dead Are Necessary (according to Hamas)
https://www.youtube.com/watch?v=jn-L3J_j00M